Pharmaceutical company in
Riehen

Alpha-O Peptides AG

Since 2003 · 1–10 empl.

Alpha-O Peptides AG develops technologies in therapeutics and biotechnology and licenses them to qualified industry partners. Its patent portfolio includes peptide and protein nanoparticles for drug delivery and vaccine applications.

Ymmunobio AG

Since 2021 · 21–50 empl.

Ymmunobio AG is a preclinical biotechnology company developing antibody-based therapies for solid tumors. Its pipeline includes NPTXR-targeted antibody-drug conjugates, radioligand therapies, and bispecific and trispecific T-cell engagers.

metaShape Pharma AG

Since 2023 · 1–10 empl.

The core activity of MetaShape Pharma AG is the development and marketing of pharmaceutical products and services in the life sciences sector. The company is active in the research and development of medicines and therapies, and also offers services such as market research, asset evaluation and communication management.

Zysthera GmbH

Since 2022 · 1–10 empl.

Stamm and Friends GmbH

Since 2005 · 11–20 empl.

The company is active in the pharmaceutical industry, specifically in the field of generics. The core activity includes searching for new developments, technologies and documentation for medicinal products, identifying and qualifying manufacturers, negotiating contracts and marketing generics and other pharmaceutical products. The company has an international network and has offices in Switzerland and China.

FRIEDRICH WOLFF AG

Since 1996 · 1–10 empl.

cureab gmbh

Since 2012 · 1–10 empl.

CIMAVIS AG

Since 2020 · 1–10 empl.

Joost Louwagie Consulting

Since 2024 · 1–10 empl.